MHR Fund Management LLC
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), MHR Fund Management LLC reported 9 stock positions worth $820.6 million. Its top holding was Iovance Biotherapeutics (IOVA) at 23.5% of the portfolio, followed by Lions Gate Entmnt (23.1%) and Telesat (TSAT, 20.0%). Compared with Q1 2024, it sold out of 1. The biggest sale was an exit from Madison Square Garden Sports (MSGS).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001277742
- Portfolio Value
- $820.6M (Q2 2024)
- SEC Filing
- 0001011438-24-000461 ↗ filed Aug 14, 2024
Holdings Value
Holdings 9 stocks · $820.6M
| IOVA Iovance Biotherapeutics Inc. | 23.45% | 23,997,103 | $192.5M | No change |
| LIONS GATE ENTMNT CORP | 23.11% | 20,127,661 | $189.6M | No change |
| TSAT Telesat Corp. | 20.00% | 18,035,092 | $164.1M | No change |
| LGF.B Lions Gate Entertainment-B | 15.78% | 15,105,523 | $129.5M | No change |
| APO Apollo Global Management Inc. | 9.77% | 679,000 | $80.2M | No change |
| TWI Titan International Inc. | 7.23% | 8,005,000 | $59.3M | No change |
| SCHL Scholastic Corp. | 0.56% | 130,000 | $4.6M | No change |
| DVAX Dynavax Technologies Corp. | 0.06% | 44,499 | $500K | No change |
| OPTU Optimum Communications Inc. Class A filed as ALTICE USA INC | 0.04% | 167,800 | $342K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| MSGS Madison Square Garden Sports | Sold out | 0.00% | −0.27 |
Portfolio Buys Q1 2024 → Q2 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 11 | $1.9B | TSAT, LION, HAFN, IOVA, STRZ |
| Q1 2026 | 10 | $1.4B | TSAT, LION, HAFN, IOVA, APO |
| Q4 2025 | 10 | $1.2B | TSAT, LION, HAFN, IOVA, APO |
| Q3 2025 | 10 | $1.0B | TSAT, LION, HAFN, IOVA, APO |
| Q2 2025 | 9 | $901.6M | TSAT, LION, HAFN, APO, IOVA |
| Q1 2025 | 9 | $832.0M | TSAT, LIONS GATE ENTMNT CORP, LGF.B, IOVA, APO |
| Q4 2024 | 9 | $904.4M | TSAT, IOVA, LIONS GATE ENTMNT CORP, LGF.B, APO |
| Q3 2024 | 9 | $917.0M | TSAT, IOVA, LIONS GATE ENTMNT CORP, LGF.B, APO |
| Q2 2024 | 9 | $820.6M | IOVA, LIONS GATE ENTMNT CORP, TSAT, LGF.B, APO |
| Q1 2024 | 10 | $1.0B | IOVA, LIONS GATE ENTMNT CORP, TSAT, LGF.B, TWI |